Meta Information

ID:lithium-microdose

Name:Microdosing Lithium

Schema Version:1.5

Alternate Names

• Lithium Orotate Microdose
• Low-Dose Lithium

Active Compound

lithium

Intervention Type

therapeutic_agent

Delivery

Route:

oral

Scope:

• systemic

Regulatory Status

• us:dietary_supplement

Indication

Focus:

healthspan

Description:

Targets neuroprotection, mood stabilization, and potential longevity pathways.

Typical Protocol

• Commonly taken as lithium orotate in doses ranging from 0.3 mg to 5 mg of elemental lithium daily.
• Higher therapeutic doses of lithium carbonate/citrate for bipolar disorder require strict medical supervision and blood monitoring.

Expected Cost Mean

Low Cost:

10

High Cost:

30

Cost Type:

monthly

Description:

Cost of lithium orotate supplements; generally not covered by insurance.

Summary

Lithium, a trace element, is being explored at microdoses for its potential neuroprotective and mood-stabilizing effects relevant to healthspan. It is thought to influence pathways like GSK-3β inhibition, autophagy, and neurogenesis, contributing to cellular resilience and brain health. Research suggests potential benefits for cognitive function and reduced risk of neurodegenerative diseases, though more targeted human healthspan data is needed.

Purpose

Enhances neuroprotection, stabilizes mood, and supports cellular longevity pathways.

Card Summary

Microdosing lithium explores neuroprotection and mood stabilization at very low doses.

Drug Class

lithium

Drugs In Class

Empty Array

Impact

Score:

6.5

Justification:

Emerging evidence for cognitive, mood, and neuroprotective healthspan benefits.

Evidence

Grade:

B

Score:

6.5

Justification:

Observational data and some small human trials support cognitive and mood benefits.

Safety

Score:

4.5

Justification:

Generally well-tolerated at microdoses but requires monitoring, especially for kidney health.

Flags

• Requires physician consultation, especially if on other medications or with kidney conditions.
• Risk of toxicity at higher doses; blood level monitoring is crucial for therapeutic use.
• Potential for interaction with diuretics, ACE inhibitors, and NSAIDs.
• Long-term safety data for chronic microdosing specifically for healthspan is still accumulating.

Verdict

Promising for neuroprotection; requires careful individual assessment and monitoring.